Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines

Multilevel factors shaping blinatumomab delivery across diverse LMICs

Building the cancer system of the future in UAE

Equitable HPV vaccination for all

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

Using artificial intelligence to improve lung cancer screening and risk prediction

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC

Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC